IP Library Granted Patent US 7,030,218
Granted Patent B2
US 7,030,218 · App. 10/332,386 · Granted Apr 18, 2006

Pseudo native chemical ligation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,030,218
App. No.
10/332,386
Granted
Apr 18, 2006
Kind
B2
Abstract

The present invention concerns methods and compositions for extending the technique of native chemical ligation of a wider range of peptides, polypeptides, other polymers and other molecules via an amide bond (see FIG. 1 ). The invention further provides methods and uses for such proteins and derivatized proteins. The invention is particularly suitable for use in the synthesis of optionally polymer-modified, synthetic bioactive proteins, and of pharmaceutical compositions that contain such proteins.

Claims (10)

1. A method for synthesizing a desired polypeptide of formula:

aa NH 2 -Q-aa x -aa y -W-aa COOH

wherein Q and W each denote the optional presence of one or more additional amino acid residues, aa NH 2 denotes the N-terminal amino acid residue of the polypeptide; aa x and aa y denote internal adjacent amino acid residues, having side chains x and y, respectively, and wherein aa y is a non-ribosomally synthesized amino acid residue and aa COOH denotes the C-terminal amino acid residue of the polypeptide;

said method comprising:

(A) ligating a first peptide having the formula: aa NH 2 -Q-aa x -COSR, wherein R is any group compatible with the thioester group, to a second peptide having the formula: Cys-W-aa COOH to thereby form the polypeptide: aa NH 2 -Q-aa x -Cys-W-aa COOH ; and

(B) incubating said polypeptide in the presence of a reagent R aa -X, where R aa is a group whose structure comprises the side chain of amino acid residue aa y ; and X is a good leaving group; said incubation being under conditions sufficient to form said desired polypeptide.

2. The method of claim 1 , wherein X is a halogen.

3. The method of claim 2 , wherein said halogen is F, I or Br.

4. The method of claim 1 , wherein said amino acid residue aa y is selected from the group consisting of a pseudo-arginine; a pseudo-asparagine; a pseudo-aspartate; a pseudo-dopamine; a pseudo-glutamate; a pseudo-glutamine; a pseudo-histidine; a pseudo-isoleucine; a pseudo-leucine; a pseudo-lysine; a pseudo-methionine; a pseudo-phenyalanine; a pseudo-serine; a pseudo-threonine; a pseudo-tryptophan; a pseudo-tyrosine; and a pseudo-valine.

5. The method of claim 1 , wherein R is an aryl, benzyl, or alkyl group.

Assignments (5)
AMYLIN PHARMACEUTICALS, LLC ASSIGNS AN EQUAL AND UNDIVIDED ONE-HALF OF ITS ENTIRE RIGHT, TITLE AND INTEREST TO ASTRAZENECA PHARMACEUTICALS LP Recorded Oct 26, 2012
From: AMYLIN PHARMACEUTICALS, LLC
To: ASTRAZENECA PHARMACEUTICALS LP
Reel/Frame 029195/0555 →
CHANGE OF NAME Recorded Oct 25, 2012
From: AMYLIN PHARMACEUTICALS, INC.
To: AMYLIN PHARMACEUTICALS, LLC
Reel/Frame 029198/0340 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 20, 2006
From: GRYPHON THERAPEUTICS, INC.
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 017042/0180 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 20, 2006
From: GRYPHON THERAPEUTICS, INC.
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 017042/0262 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2003
From: HUNTER, CHRISTIE L.; BOTTI, PAOLO; BRADBURNE, JAMES A.; CHEN, SHIAH-YUN; CRESSMAN, SONYA; KENT, STEPHEN BH.; KOCHENDOERFER, GERD G.; LOW, DONALD W.
To: GRYPHON THERAPEUTICS, INC.
Reel/Frame 014176/0872 →